 | | DRUG: Dantrolene sodium | |
| Entry |
|
|---|
| Name |
Dantrolene sodium (USP);
Dantrolene sodium hydrate (JP18);
Dantrium (TN);
Ryanodex (TN) |
|---|
| Product |
|
|---|
| Generic |
DANTROLENE (Hikma Pharmaceuticals USA), DANTROLENE SODIUM (American Health Packaging), DANTROLENE SODIUM (Amneal Pharmaceuticals of New York LLC), DANTROLENE SODIUM (AvPAK), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Bryant Ranch Prepack), DANTROLENE SODIUM (Cardinal Health 107), DANTROLENE SODIUM (Elite Laboratories), DANTROLENE SODIUM (Lannett Company), DANTROLENE SODIUM (Major Pharmaceuticals), DANTROLENE SODIUM (Par Pharmaceutical), REVONTO (USWM) |
|---|
| Formula |
(C14H9N4O5. Na)2. 7H2O
|
|---|
| Exact mass |
798.1681
|
|---|
| Mol weight |
798.5766
|
|---|
| Structure |
|
|---|
| Class |
Musculo-skeletal system agent
DG02029 Muscle relaxant
Metabolizing enzyme substrate
DG01891 CYP1A1 substrate
DG01892 CYP1A2 substrate
DG01633 CYP3A/CYP3A4 substrate
|
|---|
| Remark |
| Therapeutic category: | 1229 |
| Product (DG00778): | D02274<JP/US> |
|
|---|
| Efficacy |
Skeletal muscle relaxant |
|---|
| Disease |
|
|---|
| Metabolism |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS
M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
M03CA Dantrolene and derivatives
M03CA01 Dantrolene
D02274 Dantrolene sodium (USP) <JP/US>
USP drug classification [BR:br08302]
Antispasticity Agents
Dantrolene
D02274 Dantrolene sodium (USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
122 Skeletal muscle relaxants
1229 Others
D02274 Dantrolene sodium (USP); Dantrolene sodium hydrate (JP18)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG00778 Dantrolene
D02274 Dantrolene sodium
Metabolizing enzyme substrate
DG01891 CYP1A1 substrate
DG00778 Dantrolene
D02274 Dantrolene sodium
DG01892 CYP1A2 substrate
DG00778 Dantrolene
D02274 Dantrolene sodium
DG01633 CYP3A/CYP3A4 substrate
DG00778 Dantrolene
D02274 Dantrolene sodium
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D02274 Dantrolene sodium hydrate
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02274
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG00778 Dantrolene
Metabolizing enzyme substrate
DG01891 CYP1A1 substrate
DG00778 Dantrolene
DG01892 CYP1A2 substrate
DG00778 Dantrolene
DG01633 CYP3A/CYP3A4 substrate
DG00778 Dantrolene
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 55
1 O0 O 34.0221 -15.2964
2 C8y C 20.8070 -16.6600
3 C8y C 19.5905 -15.9606
4 O2x O 21.9470 -15.8312
5 C8x C 21.2418 -17.9998
6 C8x C 18.3741 -16.6600
7 C8x C 19.5905 -14.5503
8 C8y C 23.0871 -16.6600
9 C8x C 22.6521 -17.9998
10 C8x C 17.1578 -15.9606
11 C8x C 18.3741 -13.8510
12 C2b C 24.3033 -15.9606
13 C8y C 17.1578 -14.5503
14 N2b N 25.5257 -16.6600
15 N2b N 15.9356 -13.8510 #+
16 N1y N 26.8828 -15.9606
17 O3a O 14.6724 -14.6441
18 O3a O 15.9414 -12.4407 #-
19 C1x C 28.0348 -16.5247
20 C5x C 26.8948 -14.5503
21 C5x C 28.9750 -15.4789
22 N1x N 28.3167 -14.2624 #-
23 O5x O 25.8547 -13.8914
24 O5x O 30.2798 -15.4850
25 Z Na 28.2099 -12.8800 #+
26 O0 O 34.0221 -15.2964
27 O0 O 34.0221 -15.2964
28 O0 O 34.0221 -15.2964
29 O0 O 34.0221 -15.2964
30 O0 O 34.0221 -15.2964
31 O0 O 34.0221 -15.2964
32 C8y C 20.8070 -16.6600
33 C8y C 19.5905 -15.9606
34 C8x C 18.3741 -16.6600
35 C8x C 17.1578 -15.9606
36 C8y C 17.1578 -14.5503
37 N2b N 15.9356 -13.8510 #+
38 O3a O 14.6724 -14.6441
39 O3a O 15.9414 -12.4407 #-
40 C8x C 18.3741 -13.8510
41 C8x C 19.5905 -14.5503
42 O2x O 21.9470 -15.8312
43 C8y C 23.0871 -16.6600
44 C2b C 24.3033 -15.9606
45 N2b N 25.5257 -16.6600
46 N1y N 26.8828 -15.9606
47 C1x C 28.0348 -16.5247
48 C5x C 28.9750 -15.4789
49 O5x O 30.2798 -15.4850
50 N1x N 28.3167 -14.2624 #-
51 C5x C 26.8948 -14.5503
52 O5x O 25.8547 -13.8914
53 C8x C 22.6521 -17.9998
54 C8x C 21.2418 -17.9998
55 Z Na 28.2099 -12.8800 #+
BOND 50
1 2 3 1
2 2 4 1
3 2 5 2
4 3 6 2
5 3 7 1
6 4 8 1
7 5 9 1
8 6 10 1
9 7 11 2
10 8 12 1
11 10 13 2
12 12 14 2
13 13 15 1
14 14 16 1
15 15 17 2
16 15 18 1
17 16 19 1
18 16 20 1
19 19 21 1
20 20 22 1
21 20 23 2
22 21 24 2
23 8 9 2
24 11 13 1
25 21 22 1
26 32 33 1
27 32 42 1
28 32 54 2
29 33 34 2
30 33 41 1
31 42 43 1
32 54 53 1
33 34 35 1
34 41 40 2
35 43 44 1
36 35 36 2
37 44 45 2
38 36 37 1
39 45 46 1
40 37 38 2
41 37 39 1
42 46 47 1
43 46 51 1
44 47 48 1
45 51 50 1
46 51 52 2
47 48 49 2
48 43 53 2
49 40 36 1
50 48 50 1
BRACKET 1 32.0600 -16.3100 32.0600 -14.2100
1 34.5100 -14.2100 34.5100 -16.3100
1 7
ORIGINAL 1 1
REPEAT 1 26 27 28 29 30 31
2 14.2100 -18.2700 14.2100 -11.9000
2 30.7300 -11.9000 30.7300 -18.2700
2 2
ORIGINAL 2 2 3 6 10 13 15 17 18 11 7 4 8 12 14 16 19
2 21 24 22 20 23 9 5 25
REPEAT 2 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47
2 48 49 50 51 52 53 54 55
|
|---|
|
» Japanese version » Back
|
|